GH
Therapeutic Areas
Sequentify Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NF1 Panel | Genetic testing for Neurofibromatosis type 1 | Commercial |
| RAD21 Panel | Genetic testing for cohesin complex disorders | Commercial |
Leadership Team at Sequentify
TF
Tom Fleischer, PhD
Co‑Founder & CEO
TB
Tamir Biezuner, PhD
Co‑Founder & CSO
LS
Liran Shlush, MD, PhD
Board Member
JM
Jacob Moran‑Gilad, MD, MPH, FESCMID
Board Member
DS
Dorit Sokolov, B.Pharm, MBA
Board Member
RM
Ravindra Majeti, MD, PhD
Board Member
VD
Valerie Darling
Board Member